Reach Us +1-217-403-9671
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Translational Research on Amyotrophic Lateral Sclerosis (ALS): The Preclinical SOD1 Mouse Model

Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease and is clinically defined by the degeneration of upper and lower motor neurons, leading to paralysis and premature death. 10% of ALS patients suffer from the familial form of the disease and research has revealed a number of responsible mutations in specific genes and loci. Transgenic mouse models carrying human ALS related mutations have been generated for the study of the mechanisms involved in the disease pathogenesis and putative therapies. Mutations in the Cu/ Zn superoxide dismutase 1 (SOD1) gene, accounting for 20% of fALS and up to 5% of sALS, were the first identified to be involved in the disease. In this review, we focus on the first transgenic model used, the SOD1 mouse, which recapitulates many symptoms of the human ALS pathology. SOD1 mouse models have been extensively studied in basic and translational research, in order to unravel the underlying mechanisms, the early signs of the disorder and potential therapeutic interventions. In basic research this model has provided valuable information about ALS causes and progression. In translational research, encouraging results have emerged, but the need for better design of clinical trials is evident. This review presents the impact of the SOD1 mouse models in ALS investigation.


Author(s):

Maria Mina, Eleni Konsolaki and Laskaro Zagoraiou*



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • Advances in Brain Injury, Disorders and Therapeutics
    October 21-22, 2019 | Tokyo, Japan
  • Down Syndrome, Autism & Cerebral Palsy
    Oct 21-22, 2019 Tokyo, Japan
  • Neuroimmunology and Neuroinflammation Conference: From Discovery to Health
    November 11-12, 2019 Istanbul, Turkey
  • 32nd Clinical Neuroscience and Neurogenetics Conference
    November 19-20, 2019 Istanbul, Turkey
Flyer image

Abstracted/Indexed in

  • Google Scholar
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Secret Search Engine Labs